Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
885 Queen Anne Rd
Teaneck, NJ 07666Phone+1 201-723-0278Fax+1 201-862-1008
Education & Training
NYU Grossman School of MedicineResidency, Pediatrics, 1970 - 1973- New York University School of MedicineClass of 1970
Certifications & Licensure
VA State Medical License Current
NY State Medical License 1971 - 2026
NJ State Medical License 1981 - 2025- American Board of Pediatrics Pediatrics
Clinical Trials
- High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2014 Nov 26
Publications & Presentations
PubMed
- 22 citationsInterleukin-2, Ipilimumab, and Anti-PD-1: Clinical Management and the Evolving Role of Immunotherapy for the Treatment of Patients With Metastatic MelanomaTasha Hughes, Matthew M. Klairmont, William H. Sharfman, Howard L. Kaufman
Cancer Biology & Therapy. 2021-11-19 - 12 citationsClinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.Michael P Wu, Katherine L. Reinshagen, Mary Beth Cunnane, Sophia Z Shalhout, Howard L. Kaufman
The Laryngoscope. 2021-11-19 - 4 citationsSynthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.Jennifer Cable, Joshua N. Leonard, Timothy K. Lu, Zhen Xie, Matthew Wook Chang
Annals of the New York Academy of Sciences. 2021-11-16
Press Mentions
ImmVira Appoints Howard L. Kaufman, M.D. As Consulting Medical AdvisorAugust 24th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
